"Concise industry news from the US pharmaceutical industry..."
New Account

The Magazine

Issue 11

E-magazine
  • Previous Issues

Blog

Spencer Green
Chairman, GDS International

Sales and the 'Talent Magnet'

A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?
25 May 2011

The Path to Relief – Outsourcing as a Competitive Tool

No Comments

Pharmaceutical manufacturing and distribution have never been easy. Pharmaceutical products – from conception to actual use – can take as long as 15 years and cost upwards of $500 million to produce. Even today, U.S. Food and Drug Administration (FDA) approval no longer signals the “pop the champagne” celebration it once did.

While a drug product may have a post-approval patent life of 8 to 10 years, it also has less than a 30 percent chance of becoming a blockbuster product. It takes a company time to recoup its research and development investment. Various regulations, new market distribution models and the ever-increasing pressure to obtain bigger margins keep the bubbly in the bottle for longer periods of time.

Given the industry’s intense competition, market channel diversification is a mantra for many. Traditional pharmaceutical and medical device companies, along with newer biotech and equipment enterprises, are increasingly working together to produce systems that link drugs with devices and diagnostics. Their products are sent to consumers through multiple distribution channels: traditional wholesale, direct to pharmacies, to retailers for sale over-the-counter and directly to consumers’ homes.

These diversified channels can provide new revenue streams and new growth areas. However, manufacturers’ focus can be lost and critical errors made, particularly in transportation and distribution, when dozens of participants are involved.

Outsourcing supply chain operations is increasing for companies to regain their focus and remain competitive despite new market challenges. A third-party logistics (3PL) provider can help streamline the process – particularly in post-manufacturing handling and distribution.

In fact, more than two-thirds of pharmaceutical, medical device and diagnostics manufacturers surveyed in recent years by consultants at PRTM said they use or plan to soon use a 3PL. By using a 3PL, products can be moved quickly from manufacturing site to store shelf or dispensary. Quick market introduction is enabled because the distribution channels are already in place.

Outsourcing: The Key to Smooth Operations

Pharmaceutical companies face regulatory and quality control obligations that can include strict distribution and tight temperature control requirements. Other requirements such as meeting rigid deadlines create a separate host of challenges. Luckily, there are 3PL providers that can provide solutions to these challenges that would otherwise require a significant investment of time and money by the manufacturer. A reputable 3PL not only establishes capabilities that are sensitive and responsive to government regulations and industry standards, but also work closely with customers to understand and manage their expectations.

The demands and skill required to effectively manage orders and vendors, warehouse operations, inventory and transportation can distract manufacturers from the core business of creating and marketing innovative pharmaceutical products. Margins can also be enhanced when overhead can be removed for dedicated facilities.

What’s paramount for healthcare is to maintain high standards and guarantee order inventory and delivery accuracy. Working with a knowledgeable third party can provide a process to not only manage existing inventory, but also to document the lifecycle of the product.

A Reason To Celebrate

Healthcare manufacturers have an opportunity to turn an outsourced supply chain into a competitive advantage in four key ways:

  • Integrated 3PLs deliver enhanced economies of scale. Distribution costs can be reduced because the 3PL partner creates operational efficiencies and spreads its investment in equipment, facilities, labor and systems, as well as purchased transportation, across a broader customer base.
  • Leveraging the breadth and scope of a 3PL provider’s service portfolio puts smaller or newer industry entrants on competitive footing with their larger business rivals. They can tap into value-added combinations optimized to meet healthcare industry needs, but differentiated for product requirements, service responsiveness and coordinated channel flow.
  • Outsourced service providers have turnkey shared utility solutions that require minimal capital investment. The healthcare executive can then assign the balance of the financial resources to meet strategic business objectives. With a third-party logistics partner, the options expand.
  • Beyond bottom-line efficiencies, outsourced logistics providers can also positively contribute to clients' top-line sales growth through high-quality, customer-focused service delivery. Leading corporations in all sectors of the global economy understand that product and price differentiation can contribute to marketplace success, but consistent customer service delivery drives it.


Better informed and more demanding consumers and channel partners make good customer service crucial to operating a profitable business. Pharmaceutical, medical and surgical product makers have learned from their peers in the high-tech and consumer electronics sectors that a properly configured supply chain allows for visibility and product use projections. A properly configured supply chain also enhances service delivery by being reliable and providing proactive communication.

As healthcare products become increasingly sophisticated and fragile it is all the more important for companies to look at a 3PL for specialized resources. A 3PL can handle expiration management, pedigree systems, climate and security controls. Using a 3PL can be cheaper in the long run when a company lacks the requisite expertise, infrastructure, systems and skilled personnel in-house.

A 3PL may also provide customer-facing services to resolve issues and chargebacks on behalf of a manufacturer. When a pharmaceutical manufacturer allows a 3PL to handle customer issues and chargebacks they are not conceding control. Rather, they ensure accountability by having in place performance measures.

3PLs Improve New and Old Companies Operations

The methodology used to redesign a supply chain for well established healthcare companies can also benefit new companies. A 3PL can help both more efficiently enter new markets as they migrate from legacy systems and infrastructure to newer technology. Newer pharmaceutical companies can eliminate supply chain problems altogether by using an outsourced partner. By doing so, the company can focus on product development and marketing. And by using a 3PL that has multi-client facilities a company can benefit from sharing the costs of IT and distribution infrastructure.

When consistent performance on multiple levels is non-negotiable, outsourcing to a 3PL with the right resources is a path to relief. Careful partner selection helps effectively manage distribution costs and maintain quality inventory management in the face of increased demands.

About the author

Bill Hook is UPS Vice President of global strategy for healthcare logistics, where he ensures UPS meets healthcare customer’s unique needs. UPS provides valuable services to pharmaceutical, biotech, medical device and medical equipment companies with solutions that leverage UPS transportation networks, facilities, IT, distribution, inventory management, visibility and regulatory compliance capabilities.

Hook has more than 20 years of healthcare leadership having served as president of Livingston Healthcare Services Inc., which UPS acquired in 2000. He also was President and Chief Operating Officer at Medigas Inc., a division of Praxair Canada, Inc. Prior to accepting his current assignment he was vice president of strategic accounts-healthcare for UPS. He has a bachelor’s degree in business administration, graduating with honors from the Richard Ivey School of Business in London, Ontario.


More like this...

  • Survive and Thrive

    Four years ago it looked like Schering-Plough might not survive the patent loss of Claritin. Twelve consecutive quarters of adjusted sales growth and substantial R&D...
    Read more
  • New Business Value

    Giles Day, Senior Director of the Targets and Mechanisms Informatics Group, Pfizer explains the three areas that he is focusing on to become more...

    Read more
  • Translational Research and Biomarkers

    Dominic Spinella, Head of Translational Medicine for Pfizer Oncology, explains the concept and how this new research will help pharma move forward.
    Read more
  • Prioritization of Vaccines

    At the September 2007 NGP Discovery & Development Summit in Arizona,Anthony Ford-Hutchinson led a fascinating workshop on the prioritization of...

    Read more
  • Ambition and More

    Dr. Thomas Chan, SVP of Discovery and Development at ArQule gives NGP his insight into what a small biotechnology company are concentrating on in the...

    Read more
  • Moving Clinical Trials Forward

    Dr. Richard Polisson is one busy man. As well as being the Senior Vice President of Clinical Research for Genzyme, overseeing the design and implementation of clinical...

    Read more
Disclaimer: All comments posted in a personal capacity
POST A COMMENT
In order to post a comment you need to be regsitered and signed in.
Register | Sign in
No Comments Have Been Submitted
Disclaimer: All comments posted in a personal capacity